• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

Cannabis News

Kansas Lawmakers Introduce Medical Cannabis Legalization Bill

January 15, 2021 by CBD OIL

When Deseret Wellness Market President Jeremy Sumerix returned to his home state of Utah to launch a business in the state’s nascent medical cannabis market, he crafted a retail operation focused first and foremost on patient experience.

“What we stand for is patient experience, completely,” Sumerix tells Cannabis Business Times and Cannabis Dispensary. “Everything that we do is geared towards limiting wait times, expediting the process and making patients feel comfortable.”

Sumerix grew up in Utah before leaving to pursue a career. Prior to his role with Deseret Wellness, Sumerix worked for a multistate cannabis operator with a presence in New York, Florida, Illinois, Nevada and Arizona. After Utah voters approved medical cannabis in November 2018, Sumerix left that particular role to pursue a cannabis business in his home state, and his team were one of only four licensees awarded two retail locations by the state. The company’s first pharmacy opened Aug. 31 in Provo, and Deseret Wellness will open its second location in Park City during the first week of February.

“I think the thing that I’m continually the most excited about, is the state is conservative by nature,” Sumerix says. “They’re very methodical and careful in what they do. I think they’ve put together a really solid program that allows us to truly take care of our patients the right way.”

Photos courtesy of Deseret Wellness

Deseret Wellness strives to create the best possible experience for its patients, which includes creating a welcoming environment inside its pharmacies.

Creating the best possible patient experience is at the forefront of Deseret Wellness’ operations, Sumerix says, and the state has been very receptive to the company’s feedback on which regulations could be tweaked to improve patient access.

“If something in the current regulations doesn’t necessarily make sense or it limits our ability to take care of the patients the right way, the state is very cooperative and collaborative, so that’s been very, very encouraging,” Sumerix says. “I’ve operated in states that are less that way, so it’s refreshing to work with partners like we have here in the state of Utah.”

Deseret Wellness has implemented a robust, two-week training program for its employees, Sumerix says, which provides education on everything from the company’s products to the state’s regulations. After completing the training program, new hires then shadow an existing employee for a week or so until they are able to answer the wide variety of questions that may come up from patients.

Utah law requires licensed pharmacists to be on-site at cannabis pharmacies during business hours, and Sumerix says the company sought the best pharmacists it could find to join its team. These pharmacists are involved in the training and onboarding of new staff members.

“We look to those pharmacists as experts in the industry and the product,” Sumerix says.

Another way Deseret Wellness strives to offer the very best patient experience is through patient education. The company provides educational materials on-site at the pharmacy, such as articles that explain the differences between cannabis varieties and the various product formulations.

Deseret Wellness also regularly invites the state’s cultivators into the pharmacy to discuss their specific cultivars and products, and how their offerings can help patients with their medical conditions.

“It’s been a great collaboration with the cultivators in the state,” Sumerix says. “We have a great relationship with them, [and] I think the patients get really excited to see them visit the pharmacy because they get to learn about the product firsthand.”

Utah’s medical cannabis law forbids open flame, so Deseret Wellness sells flower and vaporizers, as well as

Deseret Wellness sells flower and vaporizers, as well as vape cartridges, topicals, gel capsules, tinctures and sprays.

vape cartridges and topicals in the form of balms, lotions and patches. The pharmacy also carries gel capsules, tinctures and sprays.

In the future, Sumerix says Deseret Wellness will also carry cannabis concentrates for patients who might need higher-potency products.

Utah is currently developing a system that will allow the state’s licensed pharmacies to deliver medical cannabis products directly to patients, which Sumerix says will only continue to improve patient access and experience.

“That will allow us to get to patients who aren’t necessarily able to get to our pharmacy, so that’s very exciting,” he says. “[The state needs] to pin down some of the specifics of the delivery platform, the delivery service, but more than likely, it’ll allow us to get to patients who are in more rural parts of the state.”

As Deseret Wellness looks toward opening its second location in Park City, Sumerix says he hopes the company can replicate what has worked well in its Provo store, from the welcoming environment to SOPs that keep patient wait times down.

The company will also continue what Sumerix calls a “deliberate approach” to avoid the spread of COVID-19 as the pandemic rages on. Efforts include checking employees’ temperatures every morning, as well as requiring all employees and patients to wear masks while inside the pharmacy.

Deseret Wellness launched curbside pickup very quickly at the start of the pandemic, Sumerix adds, and once a patient has enrolled in Utah’s medical cannabis program and purchased product inside the pharmacy once, he or she can then leverage the company’s online ordering and curbside pickup services.

“Like everybody else, we’ve worked really hard and we’re incredibly nimble, … ready to react if and when things come up,” Sumerix says. “It’s all about being diligent and consistent, and so far, we’ve been able to do that.”

Deseret Wellness is in the final stages of construction and hiring for its Park City store, and plans to hold a ribbon cutting ceremony and open house Jan. 27 with select members of the community, including the director of Utah’s medical cannabis program. The Park City pharmacy will then open its doors to patients the following week.

Looking ahead, once its new location is up and running, Deseret Wellness aims to explore its delivery options, as well as continue its efforts to offer the best possible patient experience at both of its pharmacies.

“It’s just ensuring consistency and constantly making sure that we have the right products for the patients,” Sumerix says.

Filed Under: Cannabis News

USDA Issues Final Rule on Hemp

January 15, 2021 by CBD OIL

<![CDATA[

The U.S. Department of Agriculture has published its final rule on hemp, signaling the start of an era of stability for an industry that has been in near-constant flux since its legalization in 2018.

The final rule takes effect March 22 and replaces the USDA’s interim final rule (IFR) on hemp, which was published Oct. 31, 2019.

“With the publication of this final rule, USDA brings to a close a full and transparent rule-making process that started with a hemp listening session in March 2019,” said USDA Marketing and Regulatory Programs Under Secretary Greg Ibach in a statement. “USDA staff have taken the information you have provided through three comment periods and from your experiences over a growing season to develop regulations that meet Congressional intent while providing a fair, consistent, science-based process for states, tribes and individual producers. USDA staff will continue to conduct education and outreach to help industry achieve compliance with the requirements.”

The rule’s 300 pages outline licensing requirements, recordkeeping requirements, procedures for testing tetrahydrocannabinol (THC) concentrations, procedures for disposing of non-compliant plants and more. The THC limit for hemp remains at 0.3% despite at least hundreds—if not thousands—of comments on the IFR, as well as efforts by industry organizations, urging an increase to 1%.

In 2020, the USDA announced the delay of some requirements outlined in the IFR, including the requirement for labs to be registered by the Drug Enforcement Administration (DEA) and the requirement that producers use DEA-registered law enforcement to dispose of non-compliant plants. Those delays have been further extended under the final rule until December of 2022.

States operating under the 2014 Farm Bill will continue to be allowed to do so until Jan. 1, 2022.

Editor’s note: This is a developing story and will be updated with more information.

]]>

Filed Under: Cannabis News

Free Social Equity Mentorship Program Offered by MITA

January 15, 2021 by CBD OIL

When Deseret Wellness Market President Jeremy Sumerix returned to his home state of Utah to launch a business in the state’s nascent medical cannabis market, he crafted a retail operation focused first and foremost on patient experience.

“What we stand for is patient experience, completely,” Sumerix tells Cannabis Business Times and Cannabis Dispensary. “Everything that we do is geared towards limiting wait times, expediting the process and making patients feel comfortable.”

Sumerix grew up in Utah before leaving to pursue a career. Prior to his role with Deseret Wellness, Sumerix worked for a multistate cannabis operator with a presence in New York, Florida, Illinois, Nevada and Arizona. After Utah voters approved medical cannabis in November 2018, Sumerix left that particular role to pursue a cannabis business in his home state, and his team were one of only four licensees awarded two retail locations by the state. The company’s first pharmacy opened Aug. 31 in Provo, and Deseret Wellness will open its second location in Park City during the first week of February.

“I think the thing that I’m continually the most excited about, is the state is conservative by nature,” Sumerix says. “They’re very methodical and careful in what they do. I think they’ve put together a really solid program that allows us to truly take care of our patients the right way.”

Photos courtesy of Deseret Wellness

Deseret Wellness strives to create the best possible experience for its patients, which includes creating a welcoming environment inside its pharmacies.

Creating the best possible patient experience is at the forefront of Deseret Wellness’ operations, Sumerix says, and the state has been very receptive to the company’s feedback on which regulations could be tweaked to improve patient access.

“If something in the current regulations doesn’t necessarily make sense or it limits our ability to take care of the patients the right way, the state is very cooperative and collaborative, so that’s been very, very encouraging,” Sumerix says. “I’ve operated in states that are less that way, so it’s refreshing to work with partners like we have here in the state of Utah.”

Deseret Wellness has implemented a robust, two-week training program for its employees, Sumerix says, which provides education on everything from the company’s products to the state’s regulations. After completing the training program, new hires then shadow an existing employee for a week or so until they are able to answer the wide variety of questions that may come up from patients.

Utah law requires licensed pharmacists to be on-site at cannabis pharmacies during business hours, and Sumerix says the company sought the best pharmacists it could find to join its team. These pharmacists are involved in the training and onboarding of new staff members.

“We look to those pharmacists as experts in the industry and the product,” Sumerix says.

Another way Deseret Wellness strives to offer the very best patient experience is through patient education. The company provides educational materials on-site at the pharmacy, such as articles that explain the differences between cannabis varieties and the various product formulations.

Deseret Wellness also regularly invites the state’s cultivators into the pharmacy to discuss their specific cultivars and products, and how their offerings can help patients with their medical conditions.

“It’s been a great collaboration with the cultivators in the state,” Sumerix says. “We have a great relationship with them, [and] I think the patients get really excited to see them visit the pharmacy because they get to learn about the product firsthand.”

Utah’s medical cannabis law forbids open flame, so Deseret Wellness sells flower and vaporizers, as well as

Deseret Wellness sells flower and vaporizers, as well as vape cartridges, topicals, gel capsules, tinctures and sprays.

vape cartridges and topicals in the form of balms, lotions and patches. The pharmacy also carries gel capsules, tinctures and sprays.

In the future, Sumerix says Deseret Wellness will also carry cannabis concentrates for patients who might need higher-potency products.

Utah is currently developing a system that will allow the state’s licensed pharmacies to deliver medical cannabis products directly to patients, which Sumerix says will only continue to improve patient access and experience.

“That will allow us to get to patients who aren’t necessarily able to get to our pharmacy, so that’s very exciting,” he says. “[The state needs] to pin down some of the specifics of the delivery platform, the delivery service, but more than likely, it’ll allow us to get to patients who are in more rural parts of the state.”

As Deseret Wellness looks toward opening its second location in Park City, Sumerix says he hopes the company can replicate what has worked well in its Provo store, from the welcoming environment to SOPs that keep patient wait times down.

The company will also continue what Sumerix calls a “deliberate approach” to avoid the spread of COVID-19 as the pandemic rages on. Efforts include checking employees’ temperatures every morning, as well as requiring all employees and patients to wear masks while inside the pharmacy.

Deseret Wellness launched curbside pickup very quickly at the start of the pandemic, Sumerix adds, and once a patient has enrolled in Utah’s medical cannabis program and purchased product inside the pharmacy once, he or she can then leverage the company’s online ordering and curbside pickup services.

“Like everybody else, we’ve worked really hard and we’re incredibly nimble, … ready to react if and when things come up,” Sumerix says. “It’s all about being diligent and consistent, and so far, we’ve been able to do that.”

Deseret Wellness is in the final stages of construction and hiring for its Park City store, and plans to hold a ribbon cutting ceremony and open house Jan. 27 with select members of the community, including the director of Utah’s medical cannabis program. The Park City pharmacy will then open its doors to patients the following week.

Looking ahead, once its new location is up and running, Deseret Wellness aims to explore its delivery options, as well as continue its efforts to offer the best possible patient experience at both of its pharmacies.

“It’s just ensuring consistency and constantly making sure that we have the right products for the patients,” Sumerix says.

Filed Under: Cannabis News

Need to Know: Oakland’s ECO Cannabis Helps Marginalized and Oppressed People Break into the Industry

January 15, 2021 by CBD OIL

ECO Cannabis is operating not only for itself, but for people living in Oakland, Calif., who have been impacted by cannabis prohibition.

The vertically integrated company runs an incubation program for social equity dispensary and delivery businesses in East Oakland and purchases 50% of its product from social equity companies. Out of eight companies that ECO has been incubating, six of them have graduated. ECO also promotes diverse hiring and hires people who have been affected by the war on drugs.

Launched in January 2019, ECO has cultivation, manufacturing and retail operations. The company cultivates cannabis crops at a facility dubbed Mossrock and manufactures at another it calls Rubberrock. The two facilities, both in East Oakland, total 90,000 square feet. Its storefront is located at Telegraph Avenue in Oakland.

Employment at ECO

ECO’s employment is diverse both in terms of who works there and what they do. For instance, the company hires and promotes people who were previously incarcerated, which helps those individuals reintegrate into society, ECO CEO Kevin Ahaesy said in an email.

© Mike Rosati

Kevin Ahaesy

Adhering to an organizational structure and culture that aids those affected by cannabis prohibition goes a long way, Ahaesy said. “For example, to develop, manage and facilitate initiatives around diversity, equity inclusion, and belonging (DEIB) both internally and externally in a way that improves recruitment, hiring, retention, organizational culture, promotion, and progression for … employees … can make a remarkably positive impact on those employees’ work and life experience.”

Roughly 35 of ECO’s employees work in cultivation and manufacturing, and about 15 work in retail, Ahaesy said. When looking for employees, he said, ECO partners with “job programs that cater to those who have been formerly incarcerated and/or affected by the war on drugs. In all of our job postings we also strongly encourage those individuals, Black, Brown, indigenous, people of color, women, and LGBTQIA folks to apply.”

Employees work to produce and sell popular strains such as Airheads, Space Nugs (Airheads flower covered in kief of the same strain) and Town Gas, said ECO Executive Assistant Anna Walia.

As Walia pointed out, the city of Oakland received more than $6.5 million in grant funding from California’s Bureau of Cannabis Control and Governor’s Office of Business and Economic Development (GO-Biz) for its cannabis equity program.

“That funding covers the cost of licensing fees that equity applicants do not have to pay in the city of Oakland,” she said.

RELATED: Need to Know: State Dollars Help Sacramento Build Equity Program

Half of Oakland’s cannabis businesses must be issued to equity applicants, according to the city’s municipal code. In addition to meeting an Oakland residency requirement, these applicants must meet certain income criteria and have either lived in at least one of 21 designated Oakland Police Department beats for 10 of the past 20 years or been “convicted of a cannabis crime committed in Oakland” since Nov. 5, 1996.

ECO sponsors these cannabis companies and also “maintains that 50% of its employees are formerly incarcerated and given the opportunity to thrive in the industry,” Walia said.

The company hires “exceptional talent with a reputation for excelling in their field,” said Amber Buchanan, chief operating officer. “We then support this talent by ensuring they have all the tools for success, including custom built facilities with full sensor-based monitoring of environmentals for precision agriculture, state-of-the-art LED lighting, automated fertigation systems, and advanced closed loop extraction equipment. The safety of our consumers and employees is our top priority and our facilities are sanitized from top to bottom daily with hospital grade protocol.”

© Cornelio Greer

One of ECO’s cannabis flower product offerings

Incubating Success

Working with ECO, incubated companies have found increased success. Olando Graves, owner of My Natural Solutions, a cannabis distribution and delivery company, has been involved in Oakland’s equity program for the past 10 months. Graves was quoted in a blog post on ECO’s website, saying, “The program assisted in my ability to obtain a cannabis license and start a business.”

Furthermore, Graves said in the blog that Ahaesy “showed true sincerity in assisting and working with” him and other social equity applicants, unlike “sharks” who had approached him.

In addition, ECO has sold wholesale product to My Natural Solutions, Buchanan said.

The grant funding from BCC and GO-Biz has been a boon for the incubator program, allowing ECO “to continue to fulfill its mission in supporting marginalized and oppressed people who deserve a chance to grow in the industry with us,” Ahaesy said.

Ahaesy added that “industry, policymakers and other stakeholders” can all play a role in breaking down barriers to entry and success for Black, Brown, indigenous and people of color (BBIPOC). In addition, he said, “The industry can raise its standards in practicing diverse hiring strategies. Representation in [media and social media] also matters to folks, especially to marginalized and oppressed groups.”

“[Providing] more training programs that are cannabis management-specific for those who have had no formal education and/or training would be a valuable resource for BBIPOC in the cannabis industry,” Ahaesy said. “Making cannabis legislation more accessible and understandable for those same individuals such that they feel empowered in their cannabis careers would be another step in the right direction.”

Buchanan highlighted some developments that are on the horizon at ECO. “We are currently expanding the number of grow rooms on our main campus [Mossrock], launching a new line of manufactured products under the brand ‘Oak Town Labs,’ re-inventing our ‘Dankfoot’ brand to focus on infused products, and developing a line of health and beauty products which will be known as ‘Higher Self,’” she said.

The company also plans to expand its retail presence in 2021, offering product that Ahaesy said is “Oakland-grown, certified fresh, and less than one month old when it hits our shelves.”

Filed Under: Cannabis News

Deseret Wellness Stands for Patient Experience in Utah’s Medical Cannabis Market: The Starting Line

January 15, 2021 by CBD OIL

When Deseret Wellness Market President Jeremy Sumerix returned to his home state of Utah to launch a business in the state’s nascent medical cannabis market, he crafted a retail operation focused first and foremost on patient experience.

“What we stand for is patient experience, completely,” Sumerix tells Cannabis Business Times and Cannabis Dispensary. “Everything that we do is geared towards limiting wait times, expediting the process and making patients feel comfortable.”

Sumerix grew up in Utah before leaving to pursue a career. Prior to his role with Deseret Wellness, Sumerix worked for a multistate cannabis operator with a presence in New York, Florida, Illinois, Nevada and Arizona. After Utah voters approved medical cannabis in November 2018, Sumerix left that particular role to pursue a cannabis business in his home state, and his team were one of only four licensees awarded two retail locations by the state. The company’s first pharmacy opened Aug. 31 in Provo, and Deseret Wellness will open its second location in Park City during the first week of February.

“I think the thing that I’m continually the most excited about, is the state is conservative by nature,” Sumerix says. “They’re very methodical and careful in what they do. I think they’ve put together a really solid program that allows us to truly take care of our patients the right way.”

Creating the best possible patient experience is at the forefront of Deseret Wellness’ operations, Sumerix says, and the state has been very receptive to the company’s feedback on which regulations could be tweaked to improve patient access.

“If something in the current regulations doesn’t necessarily make sense or it limits our ability to take care of the patients the right way, the state is very cooperative and collaborative, so that’s been very, very encouraging,” Sumerix says. “I’ve operated in states that are less that way, so it’s refreshing to work with partners like we have here in the state of Utah.”

Deseret Wellness has implemented a robust, two-week training program for its employees, Sumerix says, which provides education on everything from the company’s products to the state’s regulations. After completing the training program, new hires then shadow an existing employee for a week or so until they are able to answer the wide variety of questions that may come up from patients.

Utah law requires licensed pharmacists to be on-site at cannabis pharmacies during business hours, and Sumerix says the company sought the best pharmacists it could find to join its team. These pharmacists are involved in the training and onboarding of new staff members.

“We look to those pharmacists as experts in the industry and the product,” Sumerix says.

Another way Deseret Wellness strives to offer the very best patient experience is through patient education. The company provides educational materials on-site at the pharmacy, such as articles that explain the differences between cannabis varieties and the various product formulations.

Deseret Wellness also regularly invites the state’s cultivators into the pharmacy to discuss their specific cultivars and products, and how their offerings can help patients with their medical conditions.

“It’s been a great collaboration with the cultivators in the state,” Sumerix says. “We have a great relationship with them, [and] I think the patients get really excited to see them visit the pharmacy because they get to learn about the product firsthand.”

Utah’s medical cannabis law forbids open flame, so Deseret Wellness sells flower and vaporizers, as well as vape cartridges and topicals in the form of balms, lotions and patches. The pharmacy also carries gel capsules, tinctures and sprays.

In the future, Sumerix says Deseret Wellness will also carry cannabis concentrates for patients who might need higher-potency products.

Utah is currently developing a system that will allow the state’s licensed pharmacies to deliver medical cannabis products directly to patients, which Sumerix says will only continue to improve patient access and experience.

“That will allow us to get to patients who aren’t necessarily able to get to our pharmacy, so that’s very exciting,” he says. “[The state needs] to pin down some of the specifics of the delivery platform, the delivery service, but more than likely, it’ll allow us to get to patients who are in more rural parts of the state.”

As Deseret Wellness looks toward opening its second location in Park City, Sumerix says he hopes the company can replicate what has worked well in its Provo store, from the welcoming environment to SOPs that keep patient wait times down.

The company will also continue what Sumerix calls a “deliberate approach” to avoid the spread of COVID-19 as the pandemic rages on. Efforts include checking employees’ temperatures every morning, as well as requiring all employees and patients to wear masks while inside the pharmacy.

Deseret Wellness launched curbside pickup very quickly at the start of the pandemic, Sumerix adds, and once a patient has enrolled in Utah’s medical cannabis program and purchased product inside the pharmacy once, he or she can then leverage the company’s online ordering and curbside pickup services.

“Like everybody else, we’ve worked really hard and we’re incredibly nimble, … ready to react if and when things come up,” Sumerix says. “It’s all about being diligent and consistent, and so far, we’ve been able to do that.”

Deseret Wellness is in the final stages of construction and hiring for its Park City store, and plans to hold a ribbon cutting ceremony and open house Jan. 27 with select members of the community, including the director of Utah’s medical cannabis program. The Park City pharmacy will then open its doors to patients the following week.

Looking ahead, once its new location is up and running, Deseret Wellness aims to explore its delivery options, as well as continue its efforts to offer the best possible patient experience at both of its pharmacies.

“It’s just ensuring consistency and constantly making sure that we have the right products for the patients,” Sumerix says.

Filed Under: Cannabis News

How CULTA’s Jay Bouton Works: Cannabis Workspace

January 15, 2021 by CBD OIL

SANTA FE, N.M., Jan. 14, 2021 (GLOBE NEWSWIRE) — PRESS RELEASE — Nicole Sena, a medical cannabis caregiver to her young daughter with a rare form of epilepsy, and Ultra Health have reopened their lawsuit against the New Mexico Department of Health (NMDOH) to ensure an adequate supply of medicine.

The original lawsuit, filed in August 2016, contended the plant cap regulation promulgated by NMDOH was not in accordance with the Lynn and Erin Compassionate Use Act, the enabling legislation for New Mexico’s Medical Cannabis Program.

In November 2018, then-District Judge David K. Thomson ruled the department’s plant cap was arbitrary, capricious, and frustrated the purpose of the Lynn and Erin Compassionate Use Act. Sena and Ultra Health have reopened the case due to the department’s new regulation limiting adequate supply in the program.

NMDOH was court-ordered to raise the plant cap and find a data-driven solution to provide adequate supply for patients. In fall 2019, the new cap of 1,750 plants was promulgated. Even still, the new cap has failed to have a substantial effect on adequate supply in the program.

“While it may be true that DOH was delegated the authority to regulate the system of distribution of medical marijuana in this State, it may not create its own arbitrary production number that does not have a reasonable nexus in law or fact to adequate supply for patients in the program,” Judge Thomson stated in his 60-page ruling.

The ballooning of patient enrollment to 104,655 patients statewide and the effects of the COVID-19 pandemic have created an unprecedented demand for medical cannabis and therefore an extreme strain on available medicine in the program.

Per Judge Thomson’s order and the Lynn and Erin Compassionate Use Act, NMDOH has a duty to ensure every patient in the program has a three-month, uninterrupted adequate supply of medicine.

Furthermore, evidence obtained via an Inspection of Public Records Request (IPRA) found that the determination for the plant count was tied to slowing the growth of Ultra Health.

“It is odd that we are the only state with a plant count. Right now, I am trying to figure out the last possible date to hold a rule hearing (looks like July 5) in time to control the plant expansion of Ultra. They cannot produce a new crop for 16 weeks, so I have roughly four months to manage this,” then Secretary Kathy Kunkel stated in an email to Jane Wishner, a member of the governor’s senior staff, in February 2019.

“New Mexico’s medical cannabis program remains in a perpetual cycle of crisis—there is not an adequate supply of medical cannabis in state to benefit all patients, and the price of medicine puts it out of reach for too many medically fragile patients,” said Jacob Candelaria, counsel for Sena and Ultra Health, who is also a Senator from Albuquerque. “These problems are a direct result of the department’s failure to comply with the court’s trial order, and the law, which both require the department to ensure all medical cannabis patients can access the medicine they need at an affordable price.”

“What’s also very concerning here is the way the department and the governor’s office seemingly used their authority over the Medical Cannabis Program to target and retaliate against my client,” Candelaria continued. “It’s sad that our government is more interested in slowing the growth of my client’s ability to serve patients than in performing their legal obligations under the law or the court’s trial order.”

“While Judge Thomson’s ruling was a groundbreaking moment for medical cannabis patients’ rights in New Mexico, the work to actually provide an adequate supply of medicine is far from done,” said Duke Rodriguez, CEO and president of Ultra Health. “The department has a statutorily-mandated obligation to provide an adequate supply for patients. As the state’s largest provider, we similarly have an obligation to ensure our patients are receiving the standards of care that those benefiting from any other medication would receive. Simply put, the department must stop using their regulatory authority in a manner that thwarts patient access and instead promote adequate supply directly tied to the health and wellness of more than 104,000 New Mexican lives.”

Filed Under: Cannabis News

How Should Cannabis Businesses Handle the COVID-19 Vaccine?

January 15, 2021 by CBD OIL

Cannabis genetics are the cornerstone of Green Dot Labs’ Boulder, Colo.-based concentrates operation, and according to co-founder Dave Malone, the craft beer industry provided the inspiration he needed to give the company’s unique cultivars their own identities.

Malone says the craft brewing industry started out as a select few companies with lines of beers that were almost indistinguishable among consumers, but as soon as brands began investing in marketing, consumers started gravitating toward specific brands.

The cannabis industry, he says, has a lot to learn from this approach.

“That’s what we’re aiming to do with our genetics, is give them their own identity,” Malone says. “People may prefer different brands for whatever reason, but they still look at our Cherry Fluff strain, for instance, which is [branded as] a beautiful cherry on a big pile of whipped cream, and [the marketing is] very captivating and seductive. People identify with that.”

Photo courtesy of Green Dot Labs

Green Dot Labs’ Peach Brain Freeze cultivar

Dan Banks, director of cultivation strategy for Denver- based Lightshade, echoes this sentiment, adding that marketing is beginning to play a large role in the cannabis genetics space, with name-brand recognition starting to emerge among consumers.

“You have a couple different demographics,” Banks says. “You have people who are used to getting certain things from dispensaries, [and] they want to see those things maintained. Then you have people who are interested in anything new and checking that out, and if it’s new, then they’re like, ‘I want more of that’ or ‘I want more from that lineage.’”

Founded in 2011, Lightshade is one of the largest Colorado-owned, vertically integrated cannabis operators in the state. The company operates a greenhouse operation in Denver, as well as four indoor grow facilities.

When Banks joined Lightshade in late 2019, the company was cultivating roughly a dozen varieties across its five facilities, but it has since grown its genetics library to nearly 70 cultivars, with roughly 30 in regular production.

“Over the last year and some change, we’ve grown the library of genetics in the company and then implemented what we call a phenotyping program,” Banks says. “Basically, that’s a systematic way of introducing new varieties into production and gathering information about their performance, both on the horticultural side and also on the quality [and] potency side, as well.”

Lightshade acquired vertically integrated cannabis operator Sacred Seed last summer, which provided the company with a large bank of new genetics. Heading into 2021, Lightshade will establish an in-house breeding program to produce unique and proprietary varieties.

“[We’re] really trying to get some unique variety, … while also trying to cater to consumers that are looking for specific name-brand strains, as well,” Banks says, adding, “A lot of the things that people are excited about right now, there’s a lot of marketing behind that. Sometimes that marketing has a lot of substance backing it up, and other times it’s just a lot of hype.”

Photo courtesy of Lightshade

Lightshade plans to establish an in-house breeding program this year to produce unique and proprietary cannabis varieties.

Along those same lines, Malone says that companies can invest in robust marketing for a mediocre product, but that product still won’t do as well as better-quality offerings—product quality and marketing must go hand in hand.

“You can put all of the branding in the world on a jar of undifferentiated product and it won’t do well, but if you have integrity from the core, which is your genetics, it really extrapolates the value downstream when you do add these marketing layers to the product,” he says.

Green Dot Labs is entering its seventh year and maintains an in-house breeding program to create genetics specifically for its extracts.

“A lot of cannabis companies are curating genetics through a vast network that are available worldwide, whereas we’ve taken that into our own hands and steered the ship toward the goals that we set out, [so we’re] not necessarily … at the mercy of the market to provide content for the brand,” Malone says.

As it breeds new strains, Green Dot Labs brands them, which Malone says has become especially important in recent years as consumers have started to expect more from cannabis extracts.

“The consumer wants to know more,” he says. “They want to know the heritage, the lineage, where the strain came from, [and] what kind of flavors and experience they can expect when they open the package.”

Green Dot Labs has roughly 20 branded strains in its genetics library, and Malone says the branded cultivars outsell the company’s non-branded offerings, 3-to-1.

“There is so much content out there for the average consumer,” he says. “It’s overwhelming to find what strains work best for you. Everything in the current market, specifically here in Colorado, is extremely generic. A lot of companies haven’t taken this extra measure to differentiate their genetic portfolios.”

It’s a cultivator’s responsibility to tell the consumer why his or her product is better than others through branding, Malone says. The main points of brand differentiation, he adds, will be proprietary genetics that offer unique flavors and experiences, as well as the quality and efficiency with which these cultivars are produced.

Creating a Differentiated Experience

When Green Dot Labs launched its breeding program, Malone says it took a qualitative approach. The company pursued genetics that mirrored nearly every type of fruit, from a banana to an apple, and also started breeding what he calls “gassy” varieties. Since not all genetics are created equal when it comes to performing well in the extraction process, data collected during extraction helped the Green Dot Labs team further refine its genetics offerings. Specifically, the company looked at extract yields, and pursued cultivars with differentiated flavors that offered as much resin as possible.

Green Dot Labs recently closed on a new facility in Colorado that will allow the company to expand and increase its R&D capacity as it heads into the new year.

“We’re going to be delivering new strains and new flavors that have never even been imagined by the most sophisticated cannabis connoisseur,” Malone says. “That’s the goal now.”

Another one of the company’s goals, he adds, is to find strains that perform well during solventless extraction.

Photo courtesy of Green Dot Labs

Green Dot Labs will expand its extracts line this year by improving the resin structure of its favorite plants while also creating new cultivars.

“You see a lot of connoisseurs wanting to enjoy the solventless extract, but the problem with this and why it’s so expensive is because your yields are highly unpredictable and heavily predicated on the quality of the plants you produce and the genetics,” Malone says, adding that Green Dot Labs currently has 10 cultivars in its genetics library that work well with solventless extraction.

As the company heads into 2021, it will expand its extracts line by improving the resin structure of its favorite plants while also creating new cultivars.

“We like to offer something for everyone,” Malone says. “Each consumer has a certain taste, and we don’t want to alienate anybody. We want to make it so anybody who likes cannabis can come to Green Dot Labs and this can be their one-stop shop.”

For Banks and the Lightshade team, 2021 will be focused on establishing the company’s breeding program, which will include sourcing more genetic material and identifying desirable plants to work with.

“What we’ll do is try to establish a bank of male plants that we can then use to start crossing with females, and the other thing that we’ll do is look at partnering with some of the companies that are offering genetic mapping in order to get a better understanding of the source genetics that we have,” Banks says. “You bring something in and it has a name, but is it what they’re saying it is? We don’t know, but we can look into that.”

The market continues to change rapidly as consumers gain a better understanding of terpene profiles and minor cannabinoids, adds Nick Drury, Lightshade’s director of cultivation operations, and Lightshade will lean into consumer education and marketing to address these topics.

“People are realizing that it’s not just about THC content,” Drury says. “It’s also about your overall terpene profile, and how those terpenes and cannabinoids are interacting to produce a high. As people start to increase their own education into certain things, I think what you’ll start to see in the market as a whole is a shift … in terms of what people are looking for, and a little bit more interest in specific profiles, [which will do] away with the indica/sativa/hybrid terminology. … That will open up the market to a lot of cultivars that may be low in overall THC, but they might be high in CBN and all these other cannabinoids and all the different terpene profiles. … I would say education and marketing are huge in the upcoming year.”

“I think branding is just going to become more important than ever,” Malone adds. “[With] the quality [and] the differentiation being so vast, how you present the product to the consumer is really where the rubber is going to hit the road once competition elevates to this level.”

Filed Under: Cannabis News

WeedMD Expands its Color Cannabis Brand into the Province of Quebec

January 15, 2021 by CBD OIL

As the COVID-19 pandemic rages on, cannabis businesses—many of which were deemed “essential” during coronavirus-related shutdowns—have become accustomed to implementing policies and procedures to keep their employees and customers safe, from mask-wearing and sanitation protocols to how they handle COVID testing at their facilities. Now, as the first vaccines are released across the country, primarily to frontline and health care workers to start, Bianchi & Brandt partner Laura Bianchi says cannabis businesses should develop internal policies regarding vaccination.

“It really is an evolving topic, as it has been all year long,” Bianchi tells Cannabis Business Times and Cannabis Dispensary. “It changes week to week, but I do think that cannabis companies are prepared [to handle the vaccine] because they had to deal with [the pandemic] in such a front-facing manner throughout the entirety of 2020. I think for a lot of businesses, they could say, ‘Everybody work remotely,’ and they haven’t had to come up with the thoughtful policies and procedures to keep everybody safe. Cannabis companies for the most part have, so I think that puts them ahead of the curve in going, ‘OK, now let’s figure out this next phase. How do we adopt and implement things that will make sense for our patients and our staff?’”

Businesses should be prepared to move quickly once the COVID-19 vaccine is available to the general public, Bianchi says, and when developing their policies regarding vaccination, business owners should consider that in many markets, cannabis companies operate medically. Dispensaries must be prepared to deal with ill patients who may be in higher-risk populations, and Bianchi says many of her cannabis clients are considering requiring their employees to be vaccinated for this reason.

“We always advise [that] there has to be exceptions for people who have some sort of medical issue or seriously held medical beliefs,” she says. “But this is a health care facility, so we can’t place other people and patients at risk. If we can require people to take the vaccination, it’s a benefit not only to the business owners and to all of their employees, but [also] to the patients who come in.”

Many states are “at will” employment states, Bianchi says, which means that employers have the right to establish company and workplace policies, requirements and conditions—such as those relating to mandatory vaccination—as long as they don’t violate any constitutionally protected class or right.

In addition, this past December, the Equal Employment Opportunity Commission (EEOC) determined that an employer’s act of requiring employee vaccinations alone would not violate the Americans with Disabilities Act (ADA), Bianchi says, which could further strengthen an employer’s position on required vaccinations.

Although it appears, then, that employers can legally require employees to receive the COVID-19 vaccine, Bianchi says the issue is likely going to be the subject of debate and litigation going forward.

“Employers really do need to weigh the risks and benefits of requiring vaccinations to ensure the health, safety and welfare of their employees, clients and business as a whole, versus any potential liability related to implementing such a requirement,” she says.

Many of Bianchi’s clients have asked how to approach mandatory vaccination from an operational standpoint, and she has advised them to be as detailed as possible in their policies and procedures. First and foremost, she says employers should issue a uniform vaccination policy in writing, and this policy must be carefully constructed.

For example, in many facilities, such as dispensaries and cultivation and manufacturing operations, employees cannot work remotely to slow the spread of the coronavirus, and they work in close proximity to one another. In these situations, Bianchi says it might make sense for employers to require mandatory vaccination.

“A lot of our clients also have corporate offices, and for corporate offices, there’s a little bit more flexibility in saying, ‘If we don’t want to implement a must-have vaccination policy, can some of these individuals work remotely?’” she says. “Even that can be a slippery slope because you want to make these rules and requirements cohesive across the board, but there is some flexibility where maybe you’re in a location where you don’t always have to be on-site to do work.”

“Employers really do need to weigh the risks and benefits of requiring vaccinations to ensure the health, safety and welfare of their employees, clients and business as a whole.”

– Bianchi & Brandt partner Laura Bianchi

In most cases, Bianchi advises companies to evenly apply vaccination policies across the board, and business owners should meet with their attorneys to go over exceptions to mandatory vaccine policies, including requirements for employees looking to prove that they are in a situation where they would be exempt from such a policy.

If an employee refuses to follow a mandatory vaccination policy for reasons outside of the allocated exemptions, Bianchi says an employer could legally take disciplinary action, including termination.

“Again, most states are ‘at will’ employment states, so if an employer implements a COVID-19 employee vaccination policy … and an employee simply refuses, that employee may be subject to discipline, up to and including termination,” she says. “This is also something employers may opt to contractually require through an employment agreement. In that case, an employee’s refusal would be deemed a breach of contract and in the same manner, be subject to discipline, up to and including termination.”

Employers should also consider whether they will pay for mandatory vaccines if they are not covered by health insurance, as well as the timeframe for employees to be vaccinated.

“A lot of our employers are saying, ‘We’ll do this as a group—either we’ll take our employees to a certain location, or we’ll have them come to us,’” Bianchi says. “[Many businesses] did this with COVID testing, as well, [to make] it easier for employees, so they’re not searching for a location, they’re not paying fees—the employers are taking that on when they can.”

Creating a vaccination policy for seasonal workers at cultivation facilities could also pose a challenge, she adds, and employers must decide whether to require these types of hires to receive the vaccine, as well.

“You’ve really got to think about how do we keep everybody safe?” Bianchi says. “They’re going to go home to their families, [and] we’ve seen how quickly [the virus] can spread. This is an industry where it can and certainly does spread fast, so we’re trying to think of those things ahead of time, and every business has to figure out how to function financially but also help employees who may be in vulnerable financial situations get through this.”

Filed Under: Cannabis News

Michigan’s Adult-Use Cannabis Sales Increased Significantly in 2020

January 15, 2021 by CBD OIL

<![CDATA[

Throughout the coronavirus pandemic, Michigan saw a significant increase in adult-use cannabis sales, according to a new report from Headset.

Michigan legalized adult-use cannabis in 2018 and had its first sale on Dec. 1, 2019. Although the state legalized recreational cannabis nearly two years ago, sales have yet to launch in the state’s most populous city, Detroit. 

Despite the pandemic and Detroit sales not yet launched, the data report from Headset, a company that provides leading insights into cannabis consumer trends, disclosed that adult-use cannabis sales in Michigan increased by 482% between January and December 2020, topping $500 million in sales.

Within eight months of the state’s first adult-use sale, Michigan’s medical and adult-use markets brought in $595 million combined, surpassing the Nevada market last year, which legalized recreational sales in January 2017.

The report revealed that traditional flower accounted for the majority of recreational sales at 47.8%, followed by vape pens at 20.6% and edibles at 14.9%.

Medical cannabis also saw a consistent increase in sales throughout the year. That market led cannabis sales in the state between January and June 2020; however, recreational sales took over the market in the second half of the year, exceeding medical by $5 million in July.

Looking forward, the report states that adult-use sales may continue to gross more sales than medical. Furthermore, the anticipation of adult-use cannabis hitting the Detroit market this year may further boost the predicted increase in sales of recreational cannabis.

 

]]>

Filed Under: Cannabis News

Illinois Senate Approves Legislation Aimed at Improving Social Equity in Cannabis Licensing Process

January 14, 2021 by CBD OIL

Throughout the coronavirus pandemic, Michigan saw a significant increase in adult-use cannabis sales, according to a new report from Headset.

Michigan legalized adult-use cannabis in 2018 and had its first sale on Dec. 1, 2019. Although the state legalized recreational cannabis nearly two years ago, sales have yet to launch in the state’s most populous city, Detroit. 

Despite the pandemic and Detroit sales not yet launched, the data report from Headset, a company that provides leading insights into cannabis consumer trends, disclosed that adult-use cannabis sales in Michigan increased by 482% between January and December 2020, topping $500 million in sales.

Within eight months of the state’s first adult-use sale, Michigan’s medical and adult-use markets brought in $595 million combined, surpassing the Nevada market last year, which legalized recreational sales in January 2017.

The report revealed that traditional flower accounted for the majority of recreational sales at 47.8%, followed by vape pens at 20.6% and edibles at 14.9%.

Medical cannabis also saw a consistent increase in sales throughout the year. That market led cannabis sales in the state between January and June 2020; however, recreational sales took over the market in the second half of the year, exceeding medical by $5 million in July.

Looking forward, the report states that adult-use sales may continue to gross more sales than medical. Furthermore, the anticipation of adult-use cannabis hitting the Detroit market this year may further boost the predicted increase in sales of recreational cannabis.

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 71
  • Go to page 72
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Interim pages omitted …
  • Go to page 94
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service